IPP Bureau
Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer
By IPP Bureau - May 04, 2023
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
By IPP Bureau - May 03, 2023
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Laurus Labs receives USFDA tentative approval for Dolutegravir 5mg and 10mg in HIV/AIDS treatment
By IPP Bureau - May 03, 2023
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
USFDA Advisory Committee votes n Lynparza plus Abiraterone and Prednisone for prostate cancer
By IPP Bureau - May 03, 2023
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
IMCD Colombia acquires pharma API distributor Allianz
By IPP Bureau - May 03, 2023
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
By IPP Bureau - May 03, 2023
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Healthium Medtech appoints Prashant Krishnan as Global Business Head for Advanced Wound Care and Surgery
By IPP Bureau - May 02, 2023
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData
By IPP Bureau - May 02, 2023
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Lilly's Lebrikizumab shows improved face or hand dermatitis
By IPP Bureau - May 02, 2023
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
CHMP recommends EU approval of Roche’s fixed-duration Columvi for large B-cell lymphoma
By IPP Bureau - May 02, 2023
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets
By IPP Bureau - May 02, 2023
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
By IPP Bureau - May 01, 2023
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Aptar Digital Health and Healint collaborate for Central Nervous System
By IPP Bureau - May 01, 2023
The partnership will capitalize on the combined capabilities of the two organizations
Kokilaben Hospital launches dedicated Hereditary Cancer Clinic
By IPP Bureau - May 01, 2023
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr
By IPP Bureau - May 01, 2023
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
